Drugs / JWK010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07313618 | Dec 2025 → Dec 2030 expected | oculocutaneous albinism type 1 | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JWK010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07313618 ↗ |
| Action | Restore | “with the goal of restoring pigment in the retina and improving retinal structure and function.” NCT07313618 ↗ |
| Modality | Gene therapy (AAV / viral vector) | “JWK010: AAV vector containing a coding sequence for tyrosinase.” NCT07313618 ↗ |
| Route | Other | “Suprachoroidal injection dose 1 of JWK010 in one eye” NCT07313618 ↗ |